427 related articles for article (PubMed ID: 20942667)
1. Antiretroviral treatment for children with peripartum nevirapine exposure.
Palumbo P; Lindsey JC; Hughes MD; Cotton MF; Bobat R; Meyers T; Bwakura-Dangarembizi M; Chi BH; Musoke P; Kamthunzi P; Schimana W; Purdue L; Eshleman SH; Abrams EJ; Millar L; Petzold E; Mofenson LM; Jean-Philippe P; Violari A
N Engl J Med; 2010 Oct; 363(16):1510-20. PubMed ID: 20942667
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapies in women after single-dose nevirapine exposure.
Lockman S; Hughes MD; McIntyre J; Zheng Y; Chipato T; Conradie F; Sawe F; Asmelash A; Hosseinipour MC; Mohapi L; Stringer E; Mngqibisa R; Siika A; Atwine D; Hakim J; Shaffer D; Kanyama C; Wools-Kaloustian K; Salata RA; Hogg E; Alston-Smith B; Walawander A; Purcelle-Smith E; Eshleman S; Rooney J; Rahim S; Mellors JW; Schooley RT; Currier JS;
N Engl J Med; 2010 Oct; 363(16):1499-509. PubMed ID: 20942666
[TBL] [Abstract][Full Text] [Related]
3. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.
Violari A; Lindsey JC; Hughes MD; Mujuru HA; Barlow-Mosha L; Kamthunzi P; Chi BH; Cotton MF; Moultrie H; Khadse S; Schimana W; Bobat R; Purdue L; Eshleman SH; Abrams EJ; Millar L; Petzold E; Mofenson LM; Jean-Philippe P; Palumbo P
N Engl J Med; 2012 Jun; 366(25):2380-9. PubMed ID: 22716976
[TBL] [Abstract][Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
5. Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial.
Coovadia A; Abrams EJ; Strehlau R; Shiau S; Pinillos F; Martens L; Patel F; Hunt G; Tsai WY; Kuhn L
JAMA; 2015 Nov; 314(17):1808-17. PubMed ID: 26529159
[TBL] [Abstract][Full Text] [Related]
6. Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
Lockman S; Shapiro RL; Smeaton LM; Wester C; Thior I; Stevens L; Chand F; Makhema J; Moffat C; Asmelash A; Ndase P; Arimi P; van Widenfelt E; Mazhani L; Novitsky V; Lagakos S; Essex M
N Engl J Med; 2007 Jan; 356(2):135-47. PubMed ID: 17215531
[TBL] [Abstract][Full Text] [Related]
7. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
Lallemant M; Jourdain G; Le Coeur S; Mary JY; Ngo-Giang-Huong N; Koetsawang S; Kanshana S; McIntosh K; Thaineua V;
N Engl J Med; 2004 Jul; 351(3):217-28. PubMed ID: 15247338
[TBL] [Abstract][Full Text] [Related]
8. Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.
Coovadia A; Abrams EJ; Stehlau R; Meyers T; Martens L; Sherman G; Hunt G; Hu CC; Tsai WY; Morris L; Kuhn L
JAMA; 2010 Sep; 304(10):1082-90. PubMed ID: 20823434
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir.
Dlamini JN; Hu Z; Somaroo H; Highbarger HC; Follmann DA; Dewar RL; Pau AK
Pharmacotherapy; 2011 Feb; 31(2):158-63. PubMed ID: 21275494
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral interventions for preventing breast milk transmission of HIV.
White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
[TBL] [Abstract][Full Text] [Related]
11. Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission.
Lindsey JC; Hughes MD; Violari A; Eshleman SH; Abrams EJ; Bwakura-Dangarembizi M; Barlow-Mosha L; Kamthunzi P; Sambo PM; Cotton MF; Moultrie H; Khadse S; Schimana W; Bobat R; Zimmer B; Petzold E; Mofenson LM; Jean-Philippe P; Palumbo P;
Pediatr Infect Dis J; 2014 Aug; 33(8):846-54. PubMed ID: 25222305
[TBL] [Abstract][Full Text] [Related]
12. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
Fowler MG; Qin M; Fiscus SA; Currier JS; Flynn PM; Chipato T; McIntyre J; Gnanashanmugam D; Siberry GK; Coletti AS; Taha TE; Klingman KL; Martinson FE; Owor M; Violari A; Moodley D; Theron GB; Bhosale R; Bobat R; Chi BH; Strehlau R; Mlay P; Loftis AJ; Browning R; Fenton T; Purdue L; Basar M; Shapiro DE; Mofenson LM;
N Engl J Med; 2016 Nov; 375(18):1726-1737. PubMed ID: 27806243
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
[TBL] [Abstract][Full Text] [Related]
14. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.
Nielsen-Saines K; Watts DH; Veloso VG; Bryson YJ; Joao EC; Pilotto JH; Gray G; Theron G; Santos B; Fonseca R; Kreitchmann R; Pinto J; Mussi-Pinhata MM; Ceriotto M; Machado D; Bethel J; Morgado MG; Dickover R; Camarca M; Mirochnick M; Siberry G; Grinsztejn B; Moreira RI; Bastos FI; Xu J; Moye J; Mofenson LM;
N Engl J Med; 2012 Jun; 366(25):2368-79. PubMed ID: 22716975
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
16. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
17. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
Kumwenda NI; Hoover DR; Mofenson LM; Thigpen MC; Kafulafula G; Li Q; Mipando L; Nkanaunena K; Mebrahtu T; Bulterys M; Fowler MG; Taha TE
N Engl J Med; 2008 Jul; 359(2):119-29. PubMed ID: 18525035
[TBL] [Abstract][Full Text] [Related]
18. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
19. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C;
Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418
[TBL] [Abstract][Full Text] [Related]
20. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.
Ciaranello AL; Lockman S; Freedberg KA; Hughes M; Chu J; Currier J; Wood R; Holmes CB; Pillay S; Conradie F; McIntyre J; Losina E; Walensky RP;
AIDS; 2011 Feb; 25(4):479-92. PubMed ID: 21293199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
